text.skipToContent text.skipToNavigation
Pharma & Biotech

You searched for "pbmcs"

49 Products found
Too many choices? Use the filter option on the left to narrow your product listing.
  • 1(current)
  • 2
  • 3

You searched for "pbmcs"

399 Documents found
  • Lonza L7TM hiPSC Reprogramming and hPSC Culture System – A Case Study
  • Stem Cell Research Tools for Biologically Relevant Results
    Learn how Lonza products can aide in your stem cell research
  • Pluripotent Stem Cells: From Research to Therapy
    Lonza Webinar Presentation
  • A Non-Viral Method for Modifying and Expanding Primary T Cells
    Learn how Lonza’s Cocoon® Platform, 4D-NucleofectorTM LV Unit and X-VIVOTM 15 Medium are integrated to enable non-viral genetic modification and subsequent expansion of primary T cells in a functionally-closed, automated workflow.
  • Transfection Protocol for hT Cells (stim.) - NucleofectorTM I/II/2b Device Series
    Instructions of use for transfection of stimulated human peripheral blood T cells with NucleofectorTM 1/2 Devices (incl. 1, 2b, 2N, 2S)
  • Transfection Protocol for Human T Cells (Stim.) - 96-well ShuttleTM Device
    Instructions of use for transfection of stimulated peripheral blood human T cells with the P3 Primary Cell 96-well NucleofectorTM Kit
  • Transfection Protocol for Human T Cells (Stim.) - 4D-NucleofectorTM Device
    Instructions of use for transfection of stimulated peripheral blood human T cells with the P3 Primary Cell 4D-NucleofectorTM X Kit
  • Genome Editing using NucleofectorTM Technology – Citation List
    Selected citations for genome editing using ZFN, TALEN or CRISPR/Cas9 or transposition systems (e.g. for CAR-T) in combination with Lonza's NucleofectorTM Technology.
  • Hematopoietic and Immune Cell Products - Essential Tools for Hematopoietic Research
    Lonza_Brochures_Hematopoietic_and_Immune_Cell_Products_-_Essential_Tools_for_Hematopoietic_Research.pdf
  • Primary Normal Human Cells and Media
    In Vivo Relevance. In Vitro Results. Updated and revised cell content. New in print
  • Transfection Protocol for Human B Cells - NucleofectorTM I/II/2b Device Series
    Instructions of use for transfection of human B cells with NucleofectorTM 1/2 Devices (incl. 1, 2b, 2N, 2S)
  • Primary blood and immune cells for research
    Presentation (PDF) showcasing Lonza's portfolio and capabilities of primary blood and immune cells for research.
  • Transfection Protocol for Human T Cells (Unstim.) - 4D-NucleofectorTM LV Unit
    Instructions of use for transfection of unstimulated peripheral blood human T cells with the P3 Primary Cell 4D-NucleofectorTM LV Kit
  • Transfection Protocol for hT Cells (unstim.) - NucleofectorTM I/II/2b Device Series
    Instructions of use for transfection of unstimulated human peripheral blood T cells with NucleofectorTM 1/2 Devices (incl. 1, 2b, 2N, 2S)
  • Transfection Protocol for Human DC - NucleofectorTM I/II/2b Device Series
    Instructions of use for transfection of human dendritic cells (for short-term expression) with NucleofectorTM 1/2 Devices (incl. 1, 2b, 2N, 2S)
  • Webinar – Efficient Transfection of Biologically Relevant Cells in Immunology Research (pdf)
    Lonza_Webinars_Webinar__Efficient_Transfection_of_Biologically_Relevant_Cells_in_Immunology_Research.pdf
  • Transfection Protocol for Human T Cells (Unstim.) - 96-well ShuttleTM Device
    Instructions of use for transfection of unstimulated peripheral blood human T cells with the P3 Primary Cell 96-well NucleofectorTM Kit
  • Transfection Protocol for Human T Cells (Unstim.) - 4D-NucleofectorTM Device
    Instructions of use for transfection of unstimulated peripheral blood human T cells with the P3 Primary Cell 4D-NucleofectorTM X Kit
  • Primary Cells and Media Reference Guide
    A comprehensive collection of Lonza primary cell and media products supporting many research areas.
  • 2018 Endotoxin Testing Summit Report: Entering a New Era for Endotoxin Testing
    White Paper Report provides an update on current trends from the key stakeholders in the endotixin testing community, gives details on the key topics discussed, and looks at what the future holds for endotoxin testing.
  • 1(current)
  • 2
  • 3
We use cookies to deliver the best service to you. By continuing to browse the site, you are agreeing to our use of cookies.Ok